These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 3816096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
    Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H.
    J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
    [Abstract] [Full Text] [Related]

  • 3. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP.
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [Abstract] [Full Text] [Related]

  • 4. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
    Wise RA, Malamet R, Wigley FM.
    J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB, Guseva NG, Mach ES.
    Ter Arkh; 1987 Apr; 59(4):89-92. PubMed ID: 3296288
    [Abstract] [Full Text] [Related]

  • 9. Treatment of Raynaud's phenomenon with captopril.
    Tosi S, Marchesoni A, Messina K, Bellintani C, Sironi G, Faravelli C.
    Drugs Exp Clin Res; 1987 Apr; 13(1):37-42. PubMed ID: 3297593
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM, Kayser C, Pucinelli ML, Andrade LE.
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J, Rovenský J, Tauchmannová H, Zitnan D.
    Drugs Exp Clin Res; 1985 Jan; 11(9):659-63. PubMed ID: 3916837
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R, Shariat K, von Wilmowsky H, Böhm M.
    Circulation; 2005 Nov 08; 112(19):2980-5. PubMed ID: 16275885
    [Abstract] [Full Text] [Related]

  • 17. A double-blind cross-over study of nifedipine retard in patients with Raynaud's phenomenon.
    Finch MB, Copeland S, Passmore AP, Johnston GD.
    Clin Rheumatol; 1988 Sep 08; 7(3):359-65. PubMed ID: 3067954
    [Abstract] [Full Text] [Related]

  • 18. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
    Kahan A, Weber S, Amor B, Menkes CJ, Hodara M, Degeorges M.
    Int Angiol; 1985 Sep 08; 4(2):221-3. PubMed ID: 3831143
    [Abstract] [Full Text] [Related]

  • 19. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM, Malamet R, Wise RA.
    J Rheumatol; 1987 Aug 08; 14(4):751-5. PubMed ID: 3668980
    [Abstract] [Full Text] [Related]

  • 20. [Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex].
    Varela-Aguilar JM, Sánchez-Román J, Talegón Meléndez A, Castillo Palma MJ.
    Rev Clin Esp; 1997 Feb 08; 197(2):77-83. PubMed ID: 9213861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.